Vitamin D actions to regulate calcium and skeletal homeostasis

Clinical Biochemistry

Volumn 45, Issue 12, 2012, Pages 880-886

  Anderson, Paul H ^a   Turner, Andrew G ^a   Morris, Howard A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

25 hydroxyvitamin D critical serum levels; Calcium homeostasis; Dietary calcium; Metabolic bone disease; Osteomalacia rickets; Osteoporosis; Vitamin D; Vitamin D metabolism

Indexed keywords

CYTOCHROME; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; RETINOID X RECEPTOR; VITAMIN D;

BIOSYNTHESIS; BONE MINERAL; BONE TISSUE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CELL DIFFERENTIATION; CELL METABOLISM; FRACTURE; GENE; HUMAN; KIDNEY FUNCTION; MACROPHAGE; NONHUMAN; OSSIFICATION; OSTEOCLAST; PHOSPHATE INTAKE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SKELETON; VITAMIN BLOOD LEVEL; VITAMIN D RESPONSIVE ELEMENT; VITAMIN METABOLISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CALCIUM; DIET; HOMEOSTASIS; HUMANS; PHOSPHATES; STEROID HYDROXYLASES; VITAMIN D;

EID: 84863882360     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.02.020     Document Type: Review

References (79)

1. Chin A. Opinion letter: Vitamin D - analyte of the millenium, eJIFCC: 22(1) http://www.ifcc.org/media/58827/ejifcc_v22_01_05.pdf.
2. Amling M., Priemel M., Holzmann T., Chapin K., Rueger J.M., Baron R., et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140(11):4982-4987.
3. Dardenne O., Prud'homme J., Hacking S.A., Glorieux F.H., St-Arnaud R. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). Bone 2003, 32(4):332-340.
4. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29(6):726-776.
5. De Luca H.F. Historical overview of vitamin D. Vitamin D 2011, 3-12. Elsevier, San Diego. third ed. D. Feldman, J.W. Pike, J.S. Adam (Eds.).
6. Morris H.A., Anderson P.H. Vitamin D metabolism and biological activities. Mol Cell Endocrinol 2011, 347(1-2):1-2.
7. DeLuca H.F., Schnoes H.K. Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 1976, 45:631-666.
8. Anderson P.H., O'Loughlin P.D., May B.K., Morris H.A. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone 2005, 36(4):654-662.
9. Omdahl J.L., Morris H.A., May B.K. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 2002, 22:139-166.
10. Cheng J.B., Levine M.A., Bell N.H., Mangelsdorf D.J., Russell D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 2004, 101(20):7711-7715.
11. Anderson P.H., May B.K., Morris H.A. Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev 2003, 24:13-26.
12. Morris H.A., Need A.G., Horowitz M., O'Loughlin P.D., Nordin B.E.C. Calcium absorption in normal and osteoporotic postmenopausal women. Calcif Tissue Int 1991, 49:240-243.
13. Larik R., Morris H.A., O'Loughlin P.D. Determination of Vitamin D-dependent calcium absorption by 45Ca gavage in the rat. J Steroid Biochem Mol Biol 2007, 103(3-5):517-520.
14. Armbrecht H.J., Boltz M., Strong R., Richardson A., Bruns M.E., Christakos S. Expression of calbindin-D decreases with age in intestine and kidney. Endocrinology 1989, 125(6):2950-2956.
15. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80(6 Suppl.):1689S-1696S.
16. Takeda S., Yoshizawa T., Nagai Y., Yamato H., Fukumoto S., Sekine K., et al. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology 1999, 140(2):1005-1008.
17. Erben R.G., Soegiarto D.W., Weber K., Zeitz U., Lieberherr M., Gniadecki R., et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 2002, 16(7):1524-1537.
18. Peacock M. Osteomalacia and rickets. Metabolic bone and stone disease 1993, 83-118. Churchill Livingstone, London. B.E.C. Nordin, A.G. Need, H.A. Morris (Eds.).
19. Fraser D.R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 1970, 228(273):764-766.
20. Salle B.L., Delvin E.E., Lapillonne A., Bishop N.J., Glorieux F.H. Perinatal metabolism of vitamin D. Am J Clin Nutr 2000, 71(5 Suppl.):1317S-1324S.
21. M. Kallas, F. Green, M. Hewison, C. White and G. Kline, Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review, J Clin Endocrinol Metab 2010;95(7):3111-7.
22. Anderson P.H., O'Loughlin P.D., May B.K., Morris H.A. Determinants of circulating 1,25-dihydroxyvitamin D(3) levels: the role of renal synthesis and catabolism of vitamin D. J Steroid Biochem Mol Biol 2004, 89-90:111-113.
23. Anderson P.H., Hendrix I., Sawyer R.K., Zarrinkalam R., Manavis J., Sarvestani G.T., et al. Co-expression of CYP27B1 enzyme with the 1.5kb CYP27B1 promoter-luciferase transgene in the mouse. Mol Cell Endocrinol 2008, 285(1-2):1-9.
24. Murayama A., Takeyama K., Kitanaka S., Kodera Y., Hosoya T., Kato S. The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. Biochem Biophys Res Commun 1998, 249(1):11-16.
25. Kim M.S., Kondo T., Takada I., Youn M.Y., Yamamoto Y., Takahashi S., et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009, 461(7266):1007-1012.
26. Gao X.H., Dwivedi P.P., Choe S., Alba F., Morris H.A., Omdahl J.L., et al. Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene promoter in kidney AOK-B50 cells: role of Sp1, Ets and CCAAT box protein binding sites. Int J Biochem Cell Biol 2002, 34(8):921-930.
27. Zhong Y., Armbrecht H.J., Christakos S. Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene. J Biol Chem 2009, 284(17):11059-11069.
28. Perwad F., Portale A.A. Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23. Mol Cell Endocrinol 2011, 347(1-2):17-24.
29. Antoniucci D.M., Yamashita T., Portale A.A. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006, 91(8):3144-3149.
30. Perwad F., Zhang M.Y., Tenenhouse H.S., Portale A.A. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 2007, 293(5):F1577-F1583.
31. Masuda S., Byford V., Arabian A., Sakai Y., Demay M.B., St-Arnaud R., et al. Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 2005, 146:825-834.
32. Kerry D.M., Dwivedi P.P., Hahn C.N., Morris H.A., Omdahl J.L., May B.K. Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J Biol Chem 1996, 271(47):29715-29721.
33. R. Kumar, D.N. Iachini, P.M. Neilsen, J. Kaplan, J. Michalakas, P.H. Anderson, B.K. May, H.A. Morris and D.F. Callen, Systematic characterisation of the rat and human CYP24A1 promoter, Mol Cell Endocrinol 2010;325(1-2):46-53.
34. Dwivedi P.P., Muscat G.E., Bailey P.J., Omdahl J.L., May B.K. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1. J Mol Endocrinol 1998, 20(3):327-335.
35. Dwivedi P.P., Hii C.S., Ferrante A., Tan J., Der C.J., Omdahl J.L., et al. Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450c24 (CYP24) promoter: specific functions for ERK1/ERK2 and ERK5. J Biol Chem 2002, 277(33):29643-29653.
36. Dwivedi P.P., Gao X.H., Tan J.C., Evdokiou A., Ferrante A., Morris H.A., et al. A role for the phosphatidylinositol 3-kinase-protein kinase C zeta-Sp1 pathway in the 1,25-dihydroxyvitamin D3 induction of the 25-hydroxyvitamin D3 24-hydroxylase gene in human kidney cells. Cell Signal 2010, 22(3):543-552.
37. Zierold C., Mings J.A., DeLuca H.F. Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem 2003, 88(2):234-237.
38. Gao X.H., Dwivedi P.P., Omdahl J.L., Morris H.A., May B.K. Calcitonin stimulates expression of the rat 25-hydroxyvitamin D3-24-hydroxylase (CYP24) promoter in HEK-293 cells expressing calcitonin receptor: identification of signaling pathways. J Mol Endocrinol 2004, 32(1):87-98.
39. Magno A.L., Ward B.K., Ratajczak T. The calcium-sensing receptor: a molecular perspective. Endocr Rev 2011, 32(1):3-30.
40. Thomas S.D., Need A.G., Nordin B.E. Suppression of C-terminal telopeptide in hypovitaminosis D requires calcium as well as vitamin D. Calcif Tissue Int 2010, 86(5):367-374.
41. Anderson P.H., Lee A.M., Anderson S.M., Sawyer R.K., O'Loughlin P.D., Morris H.A. The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels. J Steroid Biochem Mol Biol 2010, 121(1-2):288-292.
42. Clements M.R., Johnson L., Fraser D.R. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987, 325(6099):62-65.
43. Anderson P.H., Iida S., Tyson J.H., Turner A.G., Morris H.A. Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts. J Steroid Biochem Mol Biol 2010, 121(1-2):71-75.
44. Jesudason D., Need A.G., Horowitz M., O'Loughlin P.D., Morris H.A., Nordin B.E. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 2002, 31(5):626-630.
45. Ritter C.S., Armbrecht H.J., Slatopolsky E., Brown A.J. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 2006, 70(4):654-659.
46. Need A.G., Nordin B.E. Misconceptions - vitamin D insufficiency causes malabsorption of calcium. Bone 2008, 42(6):1021-1024.
47. Need A.G., O'Loughlin P.D., Morris H.A., Coates P.S., Horowitz M., Nordin B.E. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008, 23(11):1859-1863.
48. Heaney R.P. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005, 97(1-2):13-19.
49. I.O.M. Dietary reference intakes for calcium and vitamin D 2010, National Academies Press, Washington, DC.
50. Owen T.A., Aronow M.S., Barone L.M., Bettencourt B., Stein G.S., Lian J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991, 128(3):1496-1504.
51. Anderson P.H., Atkins G.J. The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 2008, 29(6):397-406.
52. Atkins G.J., Findlay D.M., Anderson P.H., Morris H.A. Target genes: bone proteins. Vitamin D 2011, 411-424. Elsevier Academic Press, San Diego. third edition. D. Feldman, J.W. Pike, J.S. Adams (Eds.).
53. Lai J.K., Lucas R.M., Clements M.S., Roddam A.W., Banks E. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health 2010, 10:331.
54. Morris H.A., Morrison G.W., Burr M., Thomas D.W., Nordin B.E. Vitamin D and femoral neck fractures in elderly South Australian women. Med J Aust 1984, 140(9):519-521.
55. Lips P., van Ginkel F.C., Jongen M.J., Rubertus F., van der Vijgh W.J., Netelenbos J.C. Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr 1987, 46(6):1005-1010.
56. Bischoff-Ferrari H.A., Kiel D.P., Dawson-Hughes B., Orav J.E., Li R., Spiegelman D., et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 2009, 24(5):935-942.
57. Nordin B.E., O'Loughlin P.D., Need A.G., Horowitz M., Morris H.A. Radiocalcium absorption is reduced in postmenopausal women with vertebral and most types of peripheral fractures. Osteoporos Int 2004, 15(1):27-31.
58. Nordin B.E., Morris H.A. Osteoporosis and vitamin D. J Cell Biochem 1992, 49(1):19-25.
59. Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., Arnaud S., et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992, 327(23):1637-1642.
60. Okereke O.I., Manson J.E. The VITamin D and omegA-3 triaL (VITAL): rationale and design of a large-scale randomized controlled trial. Vitamin D 2011, 2043-2055. Elsevier Academic Press, San Diego. third edition. D. Feldman, J.W. Pike, J.S. Adams (Eds.).
61. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Stuck A.E., Staehelin H.B., Orav E.J., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169(6):551-561.
62. Avenell A., Gillespie W.J., Gillespie L.D., O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009, (2):CD000227.
63. Need A.G., Morris H.A., Horowitz M., Nordin B.E. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status. Calcif Tissue Int 1997, 61(1):6-9.
64. Ebeling P.R., Wark J.D., Yeung S., Poon C., Salehi N., Nicholson G.C., et al. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab 2001, 86(9):4098-4103.
65. Anderson P.H., Atkins G.J., Turner A.G., Kogawa M., Findlay D.M., Morris H.A. Vitamin D metabolism within bone cells: effects on bone structure and strength. Mol Cell Endocrinol 2011, 347(1-2):42-47.
66. Kogawa M., Anderson P.H., Findlay D.M., Morris H.A., Atkins G.J. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol 2010, 121(1-2):277-280.
67. Kogawa M., Findlay D.M., Anderson P.H., Ormsby R., Vincent C., Morris H.A., et al. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology 2010, 151(10):4613-4625.
68. H.A. Morris and P.H. Anderson, Autocrine and paracrine actions of vitamin d, Clin Biochem Rev 2010;31(4):129-38.
69. Atkins G.J., Kostakis P., Pan B., Farrugia A., Gronthos S., Evdokiou A., et al. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 2003, 18(6):1088-1098.
70. Geng S., Zhou S., Glowacki J. Effects of 25-hydroxyvitamin D3 on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1alpha-hydroxylase. J Bone Miner Res 2011, 26:1145-1153.
71. Panda D.K., Miao D., Bolivar I., Li J., Huo R., Hendy G.N., et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004, 279(16):16754-16766.
72. Boivin G., Mesguich P., Pike J.W., Bouillon R., Meunier P.J., Haussler M.R., et al. Ultrastructural immunocytochemical localization of endogenous 1,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. Bone Miner 1987, 3(2):125-136.
73. St-Arnaud R., Naja R.P. Vitamin D metabolism, cartilage and bone fracture repair. Mol Cell Endocrinol 2011, 347(1-2):48-54.
74. Naja R.P., Dardenne O., Arabian A., St Arnaud R. Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Endocrinology 2009, 150(9):4024-4032.
75. Gardiner E.M., Baldock P.A., Thomas G.P., Sims N.A., Henderson N.K., Hollis B., et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J 2000, 14(13):1908-1916.
76. Anderson P.H., Sawyer R.K., Moore A.J., May B.K., O'Loughlin P.D., Morris H.A. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 2008, 23(11):1789-1797.
77. Morris H.A., O'Loughlin P.D., Anderson P.H. Experimental evidence for the effects of calcium and vitamin D on bone: a review. Nutrients 2010, 2:1026-1035.
78. Nordin B.E., Morris H.A. The calcium deficiency model for osteoporosis. Nutr Rev 1989, 47(3):65-72.
79. Wishart J.M., Horowitz M., Need A.G., Scopacasa F., Morris H.A., Clifton P.M., et al. Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am J Clin Nutr 1997, 65(3):798-802.